Evidences for B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice between 3 and 10 months as an age-related Alzheimer's disease model

Journal of Molecular Neuroscience : MN
Zhiyong ZhongXiaojiang Tang

Abstract

Transgenic mouse has shown great advantages in the study of Alzheimer's disease (AD) and drug screening as AD develops rapidly resent years, while more detail information of these transgenic mice and experience of application are needed. To obtain the basic background information of the B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mouse, which was reported with early onset AD, three- to ten-month-old B6C3-Tg AD mice and normal C57BL/6 mice were selected randomly to test the ability of learning memory by Morris water maze, the brain acetylcholinesterase (AChE) activity by AChE kit, and beta amyloid protein level by immunohistochemistry staining. Compared with the control group, the escape latency time of B6C3-Tg AD mice at 9 and 10 months of age is significantly longer (P < 0.05) in Morris maze test, and the activity of brain AChE is higher. β-Amyloid plaques were observed at 3 months of age and developed rapidly. Statistical analysis showed a positive correlation between the area of these plaques and the ages of B6C3-Tg AD mouse (y = 0.0355e(0.5557x), R = 0.9557). The model's behavior is conformed to simulate behaviors of human Alzheimer's disease at the early stage and may provide detail background information a new choice when...Continue Reading

References

Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Mar 29, 2001·Physiological Reviews·D J Selkoe
May 4, 2001·Trends in Genetics : TIG·P F ChapmanM F Ramsay
May 5, 2001·Biomolecular Engineering·J L JankowskyD R Borchelt
Oct 5, 2001·Trends in Genetics : TIG·B J Hock, B T Lamb
Aug 21, 2003·Neurobiology of Aging·T ReesS Brimijoin
Aug 9, 2005·The International Journal of Neuropsychopharmacology·Roger M LaneAlbert Enz
Feb 4, 2009·Current Psychiatry Reports·Marc Agronin
Jul 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Ron BrookmeyerH Michael Arrighi
Nov 1, 2011·British Journal of Clinical Pharmacology·Salvatore SalomoneFilippo Drago
Jun 19, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Junxia X Tang, Maryellen F Eckenhoff
Feb 26, 2013·Archives of Pharmacal Research·Preet Anand, Baldev Singh
Mar 12, 2013·CNS Spectrums·Jeffrey L CummingsKate Zhong
May 7, 2013·The Medical Clinics of North America·Jagan A Pillai, Jeffrey L Cummings

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.